Created in 2013 (United States), Acerta Pharma own 584 sister brands and 17477 competing brands. Acerta Pharma is owned by ASTRAZENECA, listed on the stock exchange of London Its International Securities Identification Number (ISIN) is GB0009895292. Acerta Pharma belongs to the Drug Manufacturers business sector.